<!DOCTYPE article
 PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="preprint"><?all-math-mml yes?><?use-mml?><?origin ukpmcpa?><front><journal-meta><journal-id journal-id-type="nlm-ta">bioRxiv</journal-id><journal-title-group><journal-title>bioRxiv : the preprint server for biology</journal-title></journal-title-group><issn pub-type="epub">2692-8205</issn></journal-meta><article-meta><article-id pub-id-type="manuscript">EMS206142</article-id><article-id pub-id-type="doi">10.1101/2025.05.30.656994</article-id><article-id pub-id-type="archive">PPR1029655</article-id><article-version-alternatives><article-version article-version-type="status">preprint</article-version><article-version article-version-type="number">1</article-version></article-version-alternatives><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title><italic>C9orf72</italic> polyGA knock-in mice exhibit mild motor and proteomic changes consistent with ALS/FTD</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Milioto</surname><given-names>Carmelo</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref><xref ref-type="aff" rid="A3">3</xref><xref ref-type="corresp" rid="CR1">*</xref></contrib><contrib contrib-type="author"><name><surname>Carcolé</surname><given-names>Mireia</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Zanovello</surname><given-names>Matteo</given-names></name><xref ref-type="aff" rid="A4">4</xref></contrib><contrib contrib-type="author"><name><surname>Ahmed</surname><given-names>Mhoriam</given-names></name><xref ref-type="aff" rid="A4">4</xref></contrib><contrib contrib-type="author"><name><surname>Nirujogi</surname><given-names>Raja S.</given-names></name><xref ref-type="aff" rid="A5">5</xref><xref ref-type="aff" rid="A6">6</xref></contrib><contrib contrib-type="author"><name><surname>Biggs</surname><given-names>Daniel</given-names></name><xref ref-type="aff" rid="A7">7</xref></contrib><contrib contrib-type="author"><name><surname>Katona</surname><given-names>Eszter</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Glaria</surname><given-names>Idoia</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref><xref ref-type="aff" rid="A8">8</xref></contrib><contrib contrib-type="author"><name><surname>Santos</surname><given-names>Almudena</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Devoy</surname><given-names>Anny</given-names></name><xref ref-type="aff" rid="A9">9</xref></contrib><contrib contrib-type="author"><name><surname>Fratta</surname><given-names>Pietro</given-names></name><xref ref-type="aff" rid="A4">4</xref><xref ref-type="aff" rid="A10">10</xref><xref ref-type="aff" rid="A11">11</xref></contrib><contrib contrib-type="author"><name><surname>Alessi</surname><given-names>Dario R.</given-names></name><xref ref-type="aff" rid="A5">5</xref><xref ref-type="aff" rid="A6">6</xref></contrib><contrib contrib-type="author"><name><surname>Davies</surname><given-names>Ben</given-names></name><xref ref-type="aff" rid="A7">7</xref><xref ref-type="aff" rid="A11">11</xref></contrib><contrib contrib-type="author"><name><surname>Greensmith</surname><given-names>Linda</given-names></name><xref ref-type="aff" rid="A4">4</xref><xref ref-type="aff" rid="A10">10</xref></contrib><contrib contrib-type="author"><name><surname>Fisher</surname><given-names>Elizabeth M.C.</given-names></name><xref ref-type="aff" rid="A4">4</xref><xref ref-type="aff" rid="A10">10</xref><xref ref-type="corresp" rid="CR1">*</xref></contrib><contrib contrib-type="author"><name><surname>Isaacs</surname><given-names>Adrian M.</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref><xref ref-type="aff" rid="A10">10</xref><xref ref-type="corresp" rid="CR1">*</xref></contrib></contrib-group><aff id="A1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02wedp412</institution-id><institution>UK Dementia Research Institute</institution></institution-wrap>, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/02jx3x895</institution-id><institution>University College London</institution></institution-wrap>, <city>London</city><postal-code>WC1E 6BT</postal-code>, <country country="GB">UK</country></aff><aff id="A2"><label>2</label>Department of Neurodegenerative Disease, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/02jx3x895</institution-id><institution>UCL</institution></institution-wrap> Institute of Neurology, <addr-line>Queen Square</addr-line>, <city>London</city><postal-code>WC1N 3BG</postal-code>, <country country="GB">UK</country></aff><aff id="A3"><label>3</label>Dipartimento di Scienze Farmacologiche e Biomolecolari “Rodolfo Paoletti”, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/00wjc7c48</institution-id><institution>University of Milan</institution></institution-wrap>, <city>Milan</city>, <country country="IT">Italy</country></aff><aff id="A4"><label>4</label>Department of Neuromuscular Diseases, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/02jx3x895</institution-id><institution>UCL</institution></institution-wrap> Queen Square Institute of Neurology, <city>London</city>, <postal-code>WC1N 3BG</postal-code>, <country country="GB">UK</country></aff><aff id="A5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03zj4c476</institution-id><institution>Aligning Science Across Parkinson's (ASAP)</institution></institution-wrap> Collaborative Research Network, <city>Chevy Chase</city>, <state>MD</state>, <postal-code>20815</postal-code>, <country country="US">USA</country></aff><aff id="A6"><label>6</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03x94j517</institution-id><institution>Medical Research Council (MRC)</institution></institution-wrap> Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/03h2bxq36</institution-id><institution>University of Dundee</institution></institution-wrap>, <addr-line>Dow Street</addr-line>, <city>Dundee</city>, <postal-code>DD1 5EH</postal-code>, <country country="GB">UK</country></aff><aff id="A7"><label>7</label>Wellcome Centre for Human Genetics, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/052gg0110</institution-id><institution>University of Oxford</institution></institution-wrap>, <city>Oxford</city><postal-code>OX3 7BN</postal-code>, <country country="GB">UK</country></aff><aff id="A8"><label>8</label>Research Support Service, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/0526wrz79</institution-id><institution>Institute of Agrobiotechnology</institution></institution-wrap>, CSIC-Government of Navarra, <city>Mutilva</city>, <country country="ES">Spain</country></aff><aff id="A9"><label>9</label>Maurice Wohl Clinical Neuroscience Institute, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/0220mzb33</institution-id><institution>King's College London</institution></institution-wrap>, <city>London</city><postal-code>SE5 9RT</postal-code>, <country country="GB">UK</country></aff><aff id="A10"><label>10</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02jx3x895</institution-id><institution>UCL</institution></institution-wrap> Queen Square Motor Neuron Disease Centre, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/02jx3x895</institution-id><institution>UCL</institution></institution-wrap> Queen Square Institute of Neurology, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/02jx3x895</institution-id><institution>University College London</institution></institution-wrap>, <addr-line>Queen Square</addr-line>, <city>London</city><postal-code>WC1N 3BG</postal-code>, <country country="GB">UK</country></aff><aff id="A11"><label>11</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04tnbqb63</institution-id><institution>Francis Crick Institute</institution></institution-wrap>, <addr-line>1 Midland Rd</addr-line>, <city>London</city><postal-code>NW1 1AT</postal-code>, <country country="GB">UK</country></aff><author-notes><corresp id="CR1">
<label>*</label>Correspondence to AMI (<email>a.isaacs@ucl.ac.uk</email>) or EMCF (<email>elizabeth.fisher@ucl.ac.uk</email>) or CM (<email>c.milioto@ucl.ac.uk</email>)</corresp></author-notes><pub-date pub-type="nihms-submitted"><day>04</day><month>06</month><year>2025</year></pub-date><pub-date pub-type="preprint"><day>02</day><month>06</month><year>2025</year></pub-date><permissions><ali:free_to_read/><license><ali:license_ref>https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">CC BY 4.0 International license</ext-link>.</license-p></license></permissions><abstract><p id="P1">A GGGGCC repeat expansion in <italic>C9orf72</italic> is the most common genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). The repeat expansion is translated into five different dipeptide repeat proteins: polyGA, polyGP, polyGR, polyAP and polyPR. To investigate the effect of polyGA, which is the most abundant dipeptide repeat protein in patient brains, we used CRISPR/Cas9 to insert 400 codon-optimized polyGA repeats immediately downstream of the mouse <italic>C9orf72</italic> start codon. This generated (GA)400 knock-in mice driven by the endogenous mouse <italic>C9orf72</italic> promoter, coupled with heterozygous <italic>C9orf72</italic> reduction. (GA)400 mice develop subtle pathology including mild motor dysfunction characterized by impaired rotarod performance. Quantitative proteomics revealed polyGA expression caused protein alterations in the spinal cord, including changes in previously identified polyGA interactors. Our findings show that (GA)400 mice are a complementary <italic>in vivo</italic> model to better understand C9ALS/FTD pathology and determine the specific role of single DPRs in disease.</p></abstract><kwd-group><kwd>C9orf72</kwd><kwd>frontotemporal dementia FTD</kwd><kwd>amyotrophic lateral sclerosis ALS</kwd><kwd>knock-in mouse model</kwd><kwd>GA dipeptide repeat</kwd></kwd-group></article-meta></front><body><sec id="S1" sec-type="intro"><title>Introduction</title><p id="P2">Amyotrophic lateral sclerosis (ALS) is the most frequent motor neuron disease in adults, characterised by progressive muscle weakness and atrophy leading to death typically from respiratory failure with a few years of diagnosis. Frontotemporal dementia (FTD) is the second most frequent young-onset dementia, characterised by behavioural, language and cognitive impairment. Despite these differences, ALS and FTD share clinical, neuropathological, and genetic features. A hexanucleotide GGGGCC (G<sub>4</sub>C<sub>2</sub>) repeat expansion in the first intron of the <italic>C9orf72</italic> gene is the most common genetic cause of ALS and FTD, collectively termed C9ALS/FTD [<xref ref-type="bibr" rid="R1">1</xref>]–[<xref ref-type="bibr" rid="R3">3</xref>]. Three mechanisms have been proposed to induce C9ALS/FTD pathology: (i) reduced transcription of <italic>C9orf72,</italic> (ii) the presence of sense and antisense repeat-containing RNA, (iii) expression of aberrant dipeptide repeat (DPR) proteins encoded in six frames by the hexanucleotide repeat [<xref ref-type="bibr" rid="R4">4</xref>].</p><p id="P3">The presence of the hexanucleotide repeats gives rise to repeat-associated non-ATG initiated (RAN) translation, a non-canonical protein translation mechanism that does not require an ATG start codon [<xref ref-type="bibr" rid="R5">5</xref>]. RAN translation occurs in every reading frame, encoding five different DPRs: polyGA, polyGR, polyGP, polyPA and polyPR, which all form neuronal cytoplasmic inclusions in C9ALS/FTD patient brains [<xref ref-type="bibr" rid="R6">6</xref>], [<xref ref-type="bibr" rid="R7">7</xref>]. Since the exact contribution of each DPR to disease pathogenesis is poorly understood, investigation of DPRs within the context of C9ALS/FTD is essential. We and others have demonstrated that DPR proteins are toxic <italic>in vivo</italic> and <italic>in vitro</italic> [<xref ref-type="bibr" rid="R4">4</xref>], [<xref ref-type="bibr" rid="R8">8</xref>]. A recent study of the interactome of DPRs identified interacting partner proteins involved in a variety of functions, including protein translation, signal transduction pathways, protein catabolic processes, amide metabolic processes and RNA-binding [<xref ref-type="bibr" rid="R9">9</xref>]. Although the arginine-containing polyGR and polyPR proteins (R-DPRs) are the most toxic DPRs based on studies in several systems [<xref ref-type="bibr" rid="R10">10</xref>]–[<xref ref-type="bibr" rid="R17">17</xref>], considerable evidence also shows that DPRs not containing arginine induce toxicity. In particular, polyGA, the most abundant DPR species in patients, forms highly insoluble aggregates [<xref ref-type="bibr" rid="R18">18</xref>]–[<xref ref-type="bibr" rid="R21">21</xref>]. Additionally, polyGA expression has been associated with TDP-43 phosphorylation and aggregation in cellular and mouse models, and this is a key feature in most human cases of ALS [<xref ref-type="bibr" rid="R22">22</xref>]–[<xref ref-type="bibr" rid="R24">24</xref>]. Recently, polyGA overexpression in primary rat cortical neurons has been shown to promote loss of synaptic proteins and cause autophagy defects [<xref ref-type="bibr" rid="R25">25</xref>]. Furthermore, analysis of cellular models and patient brain tissue revealed that polyGA aggregates sequester proteasome components, molecular chaperones and other proteins involved with protein folding/degradation pathways and nucleocytoplasmic transport, suggesting downstream defects in protein quality control and degradation [<xref ref-type="bibr" rid="R26">26</xref>]–[<xref ref-type="bibr" rid="R29">29</xref>].</p><p id="P4">Several mouse models have been generated to elucidate how the presence of hexanucleotide repeats leads to neurodegeneration [<xref ref-type="bibr" rid="R30">30</xref>], [<xref ref-type="bibr" rid="R31">31</xref>]. Early studies showed that <italic>C9orf72</italic> homozygous knock-out mouse models, differently from heterozygous animals, develop severe autoimmunity and lymphatic defects, suggesting C9orf72 is involved in immune cell function [<xref ref-type="bibr" rid="R32">32</xref>]–[<xref ref-type="bibr" rid="R39">39</xref>]. Mouse models of <italic>C9orf72</italic> hexanucleotide repeat expansions have also been generated though AAV-mediated delivery [<xref ref-type="bibr" rid="R40">40</xref>], [<xref ref-type="bibr" rid="R41">41</xref>], or bacterial artificial chromosome (BAC) integration [<xref ref-type="bibr" rid="R42">42</xref>]–[<xref ref-type="bibr" rid="R45">45</xref>]. Although most of these mouse models recapitulate aspects of C9ALS/FTD pathology, there is considerable variation between them, including the chromosomal site expressing the repeats, suggesting more refined models are needed [<xref ref-type="bibr" rid="R46">46</xref>]. Additionally, several mouse models have been developed to better understand the role of specific DPRs. Studies of these mice show that <italic>in vivo</italic> expression of arginine-rich DPRs (R-DPRs) can drive toxicity [<xref ref-type="bibr" rid="R13">13</xref>]–[<xref ref-type="bibr" rid="R17">17</xref>], [<xref ref-type="bibr" rid="R47">47</xref>]. Similarly, studies in mice that over-express codon-optimised polyGA show that this can drive toxicity leading to neurodegeneration, motor and behavioural abnormalities, and inflammation [<xref ref-type="bibr" rid="R29">29</xref>], [<xref ref-type="bibr" rid="R48">48</xref>]. Furthermore, expression of polyGA induces selective neuron loss, interferon responses, and phosphoTDP-43 inclusions similar to those observed in C9ALS patients [<xref ref-type="bibr" rid="R49">49</xref>]. Finally, in both cell and mouse models, antibodies targeting polyGA could reduce polyGA, polyGP, and polyGR inclusions, improve behavioural deficits, decrease neuroinflammation and neurodegeneration, and increase survival [<xref ref-type="bibr" rid="R50">50</xref>]–[<xref ref-type="bibr" rid="R53">53</xref>].</p><p id="P5">To date, multiple mechanisms have been implicated as common downstream molecular pathways in C9ALS/ FTD, including autophagy, nucleocytoplasmic transport, pre-messenger RNA splicing, stress granule dynamics, DNA damage repair, mitochondrial dysfunction, nuclear pore alterations, impaired translation, lipid dyshomeostasis and synaptic dysfunction [<xref ref-type="bibr" rid="R4">4</xref>], [<xref ref-type="bibr" rid="R54">54</xref>]–[<xref ref-type="bibr" rid="R58">58</xref>]. However, despite considerable effort, the most relevant mechanism(s) by which the repeat expansion causes C9ALS/FTD remain unclear and no effective therapies have been developed to date. Thus, to understand the role(s) of individual DPRs <italic>in vivo</italic> and determine mechanisms associated with disease progression, we generated a series of <italic>C9orf72</italic> DPR knock-in mice. We recently described polyGR and polyPR knock-in mouse models that recapitulate many aspects of C9ALS/FTD pathology, such as cortical hyperexcitability and spinal motor neuron loss, and revealed a conserved neuroprotective extracellular matrix <bold>(eCm)</bold> signature in <italic>C9orf72</italic> ALS/FTD neurons [<xref ref-type="bibr" rid="R59">59</xref>]. Here we describe polyGA knock-in mice, in which 400 polyGA repeats were inserted directly after the mouse <italic>C9orf72</italic> ATG start codon, resulting in a mouse model that expresses polyGA repeats from the <italic>C9orf72</italic> locus combined with heterozygous <italic>C9orf72</italic> reduction. We carried out phenotypic analyses of this mouse on a C57BL/6J background (the same background as our polyGR and polyPR knock-in animals) and found a mild phenotype, suggesting polyGA expression at a physiological level leads to subtle changes that are consistent with, but less pronounced, than seen in other <italic>in vivo</italic> and <italic>in vitro</italic> C9ALS/FTD experimental models.</p></sec><sec id="S2" sec-type="results"><title>Results</title><sec id="S3"><title>Generation of C9orf72 polyGA knock-in mice</title><p id="P6">In order to generate polyGA knock-in mice we adopted the same approach we used recently to generate polyGR and polyPR knock-in mice, which we will collectively refer to as R-DPR mice [<xref ref-type="bibr" rid="R59">59</xref>]. We first built patient-length, seamless, codon-optimised polyGA repeats by using recursive directional ligation [<xref ref-type="bibr" rid="R10">10</xref>], [<xref ref-type="bibr" rid="R60">60</xref>] and flanked them with epitope tags (<xref ref-type="fig" rid="F1">Fig. 1A</xref>). We then used CRISPR-Cas9 technology to insert the repeats directly after the endogenous mouse <italic>C9orf72</italic> ATG start codon in mouse embryonic stem (ES) cells (<xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 1A</xref>). We next used targeted locus amplification to identify targeted ES cells that had a single insertion site, correct targeting, and no backbone co-integration (<xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 1B-1D</xref>). Validated ES cell clones were then used to generate knock-in mice using standard procedures. Briefly, targeted ES cells (C57BL/6N) were injected into C57BL/6J blastocysts, and the resulting chimeras were crossed to wild-type C57BL/6J mice for germline transmission, founders were backcrossed to C57BL/6J animals for a minimum of 5 generations before phenotypic analysis.</p><p id="P7">Heterozygous knock-in mice and littermate controls were aged and assessed, initially for polyGA expression. We detected polyGA in brain and spinal cord of (GA)400 animals at 12 months of age using an MSD immunoassay (<xref ref-type="fig" rid="F1">Fig. 1B</xref>). As expected, at the same age, (GA)400 mice selectively expressed the knock-in sequence mRNA (<xref ref-type="fig" rid="F1">Fig. 1C</xref>). As shown previously with our R-DPR knock-in mice [<xref ref-type="bibr" rid="R59">59</xref>], (GA)400 mice exhibited a significant ~40% reduction in C9orf72 at both mRNA and protein levels in cortex and spinal cord compared to wildtype littermates (WT) mice (<xref ref-type="fig" rid="F1">Fig. 1D-F</xref>). These results show that our (GA)400 mouse line expresses polyGA, alongside <italic>C9orf72</italic> reduction.</p></sec><sec id="S4"><title>(GA)400 mice develop mild motor dysfunction</title><p id="P8">We next evaluated the motor function of (GA)400 mice. Monthly body weight measurements indicated that (GA)400 male and female animals did not differ from WT littermates up to 18 months of age (<xref ref-type="fig" rid="F2">FIG. 2A</xref>). Next, we assessed motor coordination by conducting rotarod analysis from 3 to 18 months of age. Male (GA)400 mice performed significantly worse than their WT littermates in accelerated rotarod performance from 6 months of age, with female mice showing a similar but non-significant trend in the same direction (<xref ref-type="fig" rid="F2">FIG. 2B</xref>). Additionally, we performed grip strength analysis and neither (GA)400 male nor female knock-in mice showed significant strength deficits up to 18 months of age, although (GA)400 males consistently performed less well than their littermate controls (<xref ref-type="fig" rid="F2">FIG. 2C</xref>). Based on these results, we suggest that (GA)400 mice develop a milder motor dysfunction as they age, as compared to our previously characterised R-DPR knock-in mouse models [<xref ref-type="bibr" rid="R59">59</xref>].</p></sec><sec id="S5"><title>PolyGA expression does not cause overt pathology up to 18 months of age</title><p id="P9">We next investigated whether the subtle, but prolonged motor phenotype could be associated with motor neuron loss. We performed motor neuron counts at 9, 12, and 18 months of age in the ventral horn of the lumbar spinal cord as this is where the large alpha motor neurons reside that are primarily affected in ALS. Notably, we did not observe significant alteration in motor neuron numbers, but there was a non-significant trend towards lower motor neuron numbers as the mice aged compared to WT mice (<xref ref-type="fig" rid="F3">FIG. 3A-D</xref>). In our R-DPR knock-in mice we observed motor neuron loss at 12 months of age that was confirmed using electrophysiological motor unit number estimation (MUNE) analysis [<xref ref-type="bibr" rid="R59">59</xref>]. To provide a direct comparison, we performed MUNE analysis in the hindlimbs of 12-month-old (GA)400 mice. Unlike our R-DPR knock-in mice, we did not observe a reduction in functional motor unit number in the extensor digitorum longus (EDL) muscles of (GA)400 mice when compared with WT littermates (<xref ref-type="supplementary-material" rid="SD1">SUPPLEMENTARY FIG. 2A</xref>). Additionally, we investigated whether polyGA expression causes other ALS/FTD pathological hallmarks. We conducted immunostaining analysis in 18-month-old animals and did not observe microgliosis in the lumbar spinal cord of (GA)400 mice (<xref ref-type="fig" rid="F3">FIG. 3E</xref>). Similarly, we did not detect signs of astrogliosis in the lumbar spinal cord of 18-month-old (GA)400 mice (<xref ref-type="fig" rid="F3">FIG. 3F</xref>).</p></sec><sec id="S6"><title>PolyGA expression induces proteomic alterations in the spinal cord</title><p id="P10">We performed quantitative proteomics in the lumbar spinal cord of 12-month-old (GA)400 mice, which revealed modest changes at the protein level (TABLE 1). Among these alterations were reduced levels of C9orf72 and its binding partner SMCR8 (<xref ref-type="fig" rid="F4">FIG. 4A</xref>), which confirms the reduced C9orf72 levels we observed by western blotting (<xref ref-type="fig" rid="F1">FIG 1E</xref>).</p><p id="P11">We previously observed an upregulation of ECM components in R-DPR knock-in mouse lumbar spinal cord at 12 months of age using the same quantitative proteomics approach [<xref ref-type="bibr" rid="R59">59</xref>]. However, ECM proteins were not significantly increased in (GA)400 mice at 12 months of age (<xref ref-type="supplementary-material" rid="SD1">SUPPLEMENTARY FIG. 3A</xref>). As COL6A1 was the most increased ECM component in our R-DPR knock-in mice, we measured COL6A1 levels in the (GA)400 mice using immunoblotting. We did not detect alterations in COL6A1 protein level in cortex or spinal cord of 12-month-old (GA)400 mice (<xref ref-type="supplementary-material" rid="SD1">SUPPLEMENTARY FIG. 3B</xref>). Similarly, COL6A1 volume in spinal cord of 12-month-old (GA)400 mice was not altered (<xref ref-type="supplementary-material" rid="SD1">SUPPLEMENTARY FIG. 3C</xref>).</p><p id="P12">Gene Ontology (GO) molecular processes term enrichment analysis revealed several significantly downregulated pathways in lumbar spinal cord of (GA)400 mice, including synapse proteins (<xref ref-type="fig" rid="F4">FIG. 4B</xref>), which were similarly downregulated in R-DPR knock-in spinal cord. Additionally, we compared our proteomic changes to recently published polyGA interactome studies in cells [<xref ref-type="bibr" rid="R9">9</xref>] and fruit flies [<xref ref-type="bibr" rid="R58">58</xref>] (<xref ref-type="fig" rid="F4">FIG. 4C</xref>). We found that HSPA8, a molecular chaperone previously associated with poly-GA aggregates and TDP-43 toxicity [<xref ref-type="bibr" rid="R26">26</xref>], [<xref ref-type="bibr" rid="R61">61</xref>], was influenced by polyGA expression in all three models analysed. Notably, additional polyGA interactors, including NPM1, NMT1, RPL17, and SRP54 were significantly upregulated within our (GA)400 proteomic dataset (<xref ref-type="fig" rid="F4">Fig. 4C</xref>). This analysis suggests that physiological polyGA expression affects known polyGA interactor proteins in vivo. Thus, our polyGA knock-in mice exhibit changes observed in other models and may provide insight into early pathological changes caused by polyGA.</p></sec></sec><sec id="S7" sec-type="discussion"><title>Discussion</title><p id="P13">Here, we describe a novel knock-in mouse to further investigate the role of DPR toxicity in C9ALS/FTD pathology. Using the same approach we previously adopted for R-DPR mice [<xref ref-type="bibr" rid="R59">59</xref>], we generated a mouse model that selectively expresses polyGA from the endogenous locus, with a reduced level of C9orf72, thus recapitulating two key features of C9orf72 ALS/FTD. Briefly, we inserted a codon optimised polyGA sequence immediately after and in frame with the mouse C9orf72 ATG start codon. This strategy permits us to take advantage of the endogenous mouse C9orf72 promoter and also removes one C9orf72 allele, thus reducing C9orf72 levels. Notably, we intentionally generated mouse models that focus on DPRs in isolation. This means they do not model RAN translation or RNA toxicity, which will require other approaches. On the other hand, our reductionist approach allows a direct comparison of the effects of polyGA, polyGR, and polyPR repeats in in vivo mouse models on a common genetic background.</p><p id="P14">(GA)400 mice exhibited a deficit in rotarod performance that was less prominent than in our (GR)400 and (PR)400 mice. Similarly, (GA)400 mice showed a non-significant trend towards motor neuron loss at 12 and 18 months of age, while (GR)400 and (PR)400 mice showed significant reductions in motor neurons at these timepoints. We interpret these results as showing that polyGA is not benign but is likely better tolerated and thus leads to milder effects than the R-DPRs, at least in the first 18 months of life in our mouse model. This supports evidence from several experimental models where the arginine-rich polyGR and polyPR have been shown to exert stronger neurotoxic effects than polyGA [<xref ref-type="bibr" rid="R3">3</xref>], [<xref ref-type="bibr" rid="R10">10</xref>], [<xref ref-type="bibr" rid="R30">30</xref>].</p><p id="P15">Based on our recent findings that expression of R-DPRs induces increased levels of specific ECM proteins in the spinal cord, which provide protection against neurodegeneration [<xref ref-type="bibr" rid="R59">59</xref>], we focused on spinal cord to identify potential mechanisms associated with polyGA expression. We performed proteomics analysis in the spinal cord at 12 months of age and analysed whether (GA)400 mice show the ECM signature we described in R-DPR mice and C9orf72 iPSC-derived motor neurons. However, no significant change in ECM proteins was observed. Once more, these results are consistent with the milder effects observed in polyGA knock-in mice.</p><p id="P16">While the increased ECM signature was the most striking proteomic change in (GR)400 and (PR)400 mice, we also reported downregulated pathways with lower fold-changes. Due to the modest toxicity of polyGA, we did not expect proteomics analysis to reveal a strong similarity between (GA)400 and R-DPR mice. Surprisingly, we found several GO terms related to downregulated genes in the (GA)400 mouse that were shared with the R-DPR knock-in mouse models. Notably, these GO terms are related to neuronal and cellular homeostasis including synapse, neuron projection, plasma membrane bound cell projection, cell junction, and axon, indicating neuronal/axonal or synaptic dysfunction. This observation suggests that each DPR causes neuronal dysfunction, even if GR and PR appear to be more toxic over the 18-month time frame of our studies.</p><p id="P17">Consistent with other knock-in models, the phenotypes were relatively modest across all our DPR knock-in mouse lines. This suggests that other factors are necessary in addition to DPR expression to drive the overt neuronal loss observed in patients. One possibility is an age-related decline in proteostasis that may allow higher levels of DPRs to accumulate over time, potentially closer to the levels utilised in over-expression studies that show overt toxicity and/or TDP-43 mislocalisation [<xref ref-type="bibr" rid="R24">24</xref>], [<xref ref-type="bibr" rid="R47">47</xref>], [<xref ref-type="bibr" rid="R62">62</xref>].</p><p id="P18">Since we and others have previously performed polyGA interactome studies [<xref ref-type="bibr" rid="R9">9</xref>], [<xref ref-type="bibr" rid="R58">58</xref>], we compared results obtained from these studies with our proteomics data. This comparison revealed that NPM1, NMT1, RPL17, SRP54, and HSPA8 were common across the datasets analysed. Interestingly, each of these proteins were upregulated in (GA)400 spinal cord. This could suggest a stabilising interaction with polyGA, but further studies will be required to confirm this and whether there are functional consequences. Notably, this conservation of events across several models indicates a genuine phenomenon linked to the presence of polyGA.</p><p id="P19">Overall, our study shows that our novel (GA)400 mouse model exhibits mild motor and proteomic changes that may model the earliest effects of polyGA in the brain and spinal cord. Together with our (GR)400 and (PR)400 mice, this series of DPR <italic>C9orf72</italic> knock-in mice provides a valuable tool to study the role of DPRs in <italic>vivo.</italic></p></sec><sec id="S8" sec-type="methods"><title>Methods</title><sec id="S9"><title>Assembly of targeting constructs</title><p id="P20">Assembly of targeting constructs was performed as previously described [<xref ref-type="bibr" rid="R59">59</xref>]. Briefly, 100 codon-optimised polyGA repeats were synthesized (Thermo Fisher Scientific). A pMC cloning vector was synthesized to contain 600 bp of the 5' homology arm, a double HA-tag, a V5 epitope tag, a SV40 polyA tail, and 250 bp of 3' homology arm. 100 codon-optimised DPRs were cloned into this vector within the <italic>BbsI</italic> and <italic>BsmBI</italic> sites to generate pMC-(GA)100. 400 codon-optimised DPRs were assembled with two consecutive rounds of recursive directional ligation taking advantage of the restriction enzymes <italic>BbsI</italic> and <italic>BsmBI</italic> to generate pMC-(GA)400.</p><p id="P21">A selection cassette (FRT-PGK-gb2-neo-FRT, Gene Bridges) was inserted in the pMC-(GA)400 in the <italic>NheI</italic> site. A BAC subcloning kit (Red/ET recombination, Gene Bridges) was used to clone full length homology arms (2.7 kb in 5' and 3.2 kb in 3') from the BAC clone (RP23-434N2), containing the C57BL/6J sequence of the mouse <italic>C9orf72</italic> gene, into the targeting vector pBlueScript II SK (+). Knock-in constructs were obtained by inserting sequences from pMC-(GA)400 into targeting vectors within the <italic>BstXI</italic> and <italic>XcmI</italic> sites.</p></sec><sec id="S10"><title>Animals</title><p id="P22">All procedures involving mice were conducted in accordance with the Animal (Scientific procedures) Act 1986, were performed at University College London under an approved UK Home Office project licence reviewed by the Institute of Prion Diseases Animal Welfare and Ethical Review Body and were reported according to the ARRIVE2 guidelines. Mice were maintained in a 12 h light/dark cycle at a temperature of 20°C -24°C and relative humidity of 45%-55% with food and water supplied <italic>ad libitum.</italic> The knock-in mice generated are available from the European Mutant Mouse Archive, EMMA ID EM:14658, strain name B6J.B6N-C9orf72<sup>em1.1(GR400)Asia/H</sup>.</p><p id="P23">Assembly of targeting constructs was performed as previously described [<xref ref-type="bibr" rid="R59">59</xref>]; to generate the (GA)400 mouse strain, we performed CRISPR assisted gene targeting in JM8F6 embryonic stem (ES) cells (C57BL/6N) using our targeting vector(s) and a CRISPR/Cas9 guide designed against the insertion site.</p><p id="P24">The CRISPR construct (pX330-Puro-C9orf72), expressing Cas9 and a U6 promoter driven single-guide-RNA (sgRNA) designed against the following sequence AGTCGACATCCCTGCATCCC. This was generated by annealing the following two oligos (5'-CACCgAGTCGACATCCCTGCATCCC-3'; 5'-AAACGGGATGCAGGGATGTCGACTc-3') and cloning this into the unique <italic>BbsI</italic> sites of pX330-U6-Chimeric_BB-CBh-hSpCas9 (Addgene # 42230), modified by the addition of a PGK-Puro cassette.</p><p id="P25">1x10<sup>6</sup> ES cells were electroporated with 2.5 μg of the cloned pX330-Puro-C9orf72 plasmid and 2.5 μg of targeting vector using the Neon Transfection System (Thermo Fisher Scientific) (3 x 1400 V, 10 ms) and plated on puromycin resistant fibroblast feeder layers. After approximately 24 hours, 600 ng/ml puromycin was applied for a further 48 hour to allow transient selection. After further 5 days in culture without selection, individual colonies were isolated, expanded and screened for the desired targeting at both the 5' end (5'-TCGGGGATTATGCCTGCTGC'3' and 5'-GCATCCCAGGTCTCACTGCA-3') and at the 3' end (5'-TCGAAAGGCCCGGAGATGAGGAAG-3' and 5'-GGGTTCAGACAGGTACAGCAT-3'). ES cells from correctly targeted clones were injected into albino C57BL/6J blastocysts and the resulting chimeras were mated with albino C57BL/6J females. The presence of the targeted allele in the F1 generation was confirmed at the DNA level by the above PCR and Sanger sequencing. Germline-transmitting founders were obtained and backcrossed to wild-type C57BL/6J mice to maintain hemizygous lines for a minimum of 5 generations.</p><p id="P26">Mouse genotype was determined by PCR for knock-in sequence with the following set of primers (forward 5'-TAAGCACAGCAGTCATTGGA-3' and reverse 5'-AAGCGTAATCTGGAACATCG-3'). Repeat length was determined by PCR with the following set of primers (forward 5'-CCCATACGATGTTCCAGATTACGCTTACCC-3' and reverse 5'-GCAATAAACAATTAGGTGCTATCCAGGCCCAG-3').</p><p id="P27">If not specified, males were used for all experiments in the main text. Phenotyping was performed on both male and female mice.</p></sec><sec id="S11"><title>Biochemical analysis</title><p id="P28">Brains and spinal cords were homogenized in lysis buffer [RIPA buffer (Pierce), 2% sodium dodecyl buffer (SDS), protease (Roche) and phosphatase (Thermo Fisher Scientific) inhibitors]. Lysates were sonicated and microcentrifuged for 20 min at 13000 xg at room temperature and soluble fractions collected. Proteins were separated on NuPAGE™ 4 to 12% bis-tris gels (Invitrogen) and transferred to nitrocellulose membranes (Bio-Rad Laboratories). Membranes were blocked in 5% milk in PBS-T (PBS, 0.1% Tween-20) for 1 hour at room temperature. The membranes were incubated overnight at 4 °C with the following primary antibodies: C9orf72 (12E7, kindly donated by Prof. Dr. Manuela Neumann; 1:4 dilution), COL6 (ab182744, Abcam; 1:1000), Calnexin (sc-6465, Santa Cruz Biotechnology; 1:1000 dilution), GAPDH (14C10, #2118, Cell Signaling). After 3 washes in PBS-T, membranes were incubated with secondary HRP-conjugated antibodies for 1 hour at room temperature. After 3 washes in PBS-T, signals were visualized by chemiluminescence (Amersham imager 680) and quantifications performed using ImageJ software.</p><p id="P29">Meso Scale Discovery (MSD) immunoassays were performed as previously described [<xref ref-type="bibr" rid="R63">63</xref>]–[<xref ref-type="bibr" rid="R65">65</xref>], using unlabelled anti-poly(GA) antibody (Sigma Aldrich, #MABN889) as capture, and biotinylated anti-poly(GA) (GA5F2, kindly gifted by Prof Dieter Edbauer) as detector.</p></sec><sec id="S12"><title>Quantitative reverse transcription PCR</title><p id="P30">Tissues were dissected and flash frozen. Total RNA was extracted with miRNeasy Micro Kit (Qiagen) and reverse-transcribed using SuperScript IV Reverse Transcriptase (Invitrogen) with random hexamers and Oligo(dT)<sub>20</sub> primers. Gene expression was determined by quantitative real-time PCR using a LightCycler® and SYBR green (Roche). Relative gene expression was determined using the ΔΔCT method. Primers for mouse <italic>C9orf72</italic> are: 5'-TGAGCTTCTACCTCCCACTT-3' and 5'-CTCTGTGCCTTCCAAGACAAT-3'. Primers to amplify the knock-in sequence are: 5'-GCGGCGAGTGGCTATTG-3' (primer located within mouse <italic>C9orf72</italic> gene at exon boundary 1-2) and 5'-GGGTAAGCGTAATCTGGAACATC-3' (sequence within the HA-tag sequence). Primers for mouse <italic>GAPDH</italic> are: 5'-TAGACAAAATGGTGAAGGT-3' and 5'-AGTTGAGGTCAATGAAGG-3'.</p></sec><sec id="S13"><title>Immunohistochemistry</title><p id="P31">Mice were perfused with prechilled phosphate buffered saline (PBS) and then 4% paraformaldehyde (PFA). Spinal cords were dissected and postfixed in 4% PFA at 4°C for 2 hours. After fixation, spinal cords were washed with PBS, allowed to sink in 30% sucrose solution at 4°C, then stored in 0.02% sodium azide at 4°C until further processing. Spinal cords were embedded in optimal cutting temperature (OCT) compound (Tissue Tek, Sakura, Torrance, CA), and 10 μm sections cut with a cryostat (CM1860 UV, Leica Microsystem). For immunofluorescence, cryosections were washed 3 times in PBS and blocked in 5% BSA, 1% normal goat serum, 0.2% Triton-X in PBS for 1 hour at room temperature. Sections were then incubated with primary antibodies in blocking solution overnight at 4°C. After 3 washes with PBS, sections were incubated for 1 hour at room temperature in blocking solution with secondary antibodies conjugated with Alexa 488, 546, 594, and 633 (Invitrogen). After 3 washes in PBS, sections were mounted with ProLong™ Gold Antifade Mountant with DAPI (Invitrogen).</p><p id="P32">The primary antibodies used were: IBA1 (019-19741, FUJIFILM Wako Pure Chemical Corporation; 1:500 dilution), GFAP (AB5804, Abcam; 1:500 dilution), CD68 (MCA1957, Bio-Rad Antibodies; 1:200 dilution), COL6 (ab182744, Abcam; 1:200).</p><p id="P33">Images were taken using a Zeiss LSM 880 confocal microscope or ZEISS Axio Scan.Z1 slide scanner. Image analyses were performed using ImageJ, Imaris software.</p></sec><sec id="S14"><title>Locomotor, grip strength and body weight assessment</title><p id="P34">Behavioural tests were undertaken as previously described [<xref ref-type="bibr" rid="R59">59</xref>]. Briefly, tests were performed monthly from 3- to 9-months of age, and in 12- 18-month-old mice. Motor coordination was measured by rotarod analysis (Ugo Basile). A power calculation using GPower predicted that for an effect size of 10% deviation from the group mean, with a power of 0.85 and an alpha of 0.05, groups sizes of 28 were needed, so we used 14 females and 14 males per group. Mice were trained the week before starting the test. Then, mice received a session which included three trials of accelerated rotarod for a maximum of 300 seconds. Trials started at 4 rpm speed and accelerated up to 40 rpm in 4 min, the final min of the test was performed at 40 rpm. The average of the three trials was used. A grip strength meter (Bioseb) was used to measure forelimb and hindlimb grip strength. The highest muscle force score of three independent trials was used. Body weight was measured weekly from 3-months of age. Mice were randomized into different experimental groups and the operator was blind to genotype.</p></sec><sec id="S15"><title>Motor neuron counts</title><p id="P35">10 μm-thick OCT-embedded spinal cord sections were stained with Cresyl Violet and motor neurons located within the sciatic motor pool were counted in each ventral horn, collected every 60 μm of tissue, covering L3 to L5 levels of the spinal cord.</p></sec><sec id="S16"><title><italic>In vivo</italic> isometric muscle tension physiology</title><p id="P36">Isometric muscle tension physiology was performed as previously described [<xref ref-type="bibr" rid="R66">66</xref>], [<xref ref-type="bibr" rid="R67">67</xref>]. Briefly, under deep anaesthesia (isoflurane inhalation via nose cone), hindlimbs were immobilized and the distal tendons of the TA and EDL muscles of both hindlimbs were exposed and consecutively attached to force transducers in parallel. Sciatic nerves were exposed bilaterally, at mid-thigh level, severed and the distal stumps placed in contact with stimulating electrodes. EDL muscle motor unit number estimates (MUNE) were determined by gradually increasing the amplitude of repeated square wave stimuli, thereby inducing stochastic changes in contractile force. The total number of motor units recruited over the full range of amplitudes was counted for individual muscles and averaged for each genotype.</p></sec><sec id="S17"><title>Proteomic analysis</title><p id="P37">Mouse lumbar spinal cords and cortices were solubilized in SDS-Lysis buffer (2% (weight/vol) SDS in 100 mM TEABC supplemented with Roche protease mini and Phos-STOP cocktail tablets). Automated homogenization was performed using the Precellys evolution homogenizer and Bioruptor assisted sonication. Protein estimation by BCA assay and protein quality confirmed by SDS-PAGE. 200 μg of lysate was aliquoted and processed using S-Trap assisted On-column tryptic digestion as described previously (dx.doi.org/10.17504/protocols.io.bs3tngnn). Peptide eluates were then subjected to TMT labelling and High-pH fractionation for LC-MS/MS, a total of 96 fractions were collected and pooled to 48 fractions, vacuum dried and stored at -80°C until LC-MS/MS analysis.</p><p id="P38">LC-MS/MS analysis: A total of 48 bRPLC fractions were prepared for mass spectrometry analysis using an Orbitrap Tribrid Lumos mass spectrometer in-line with an Ultimate 3000 RSLC nano-liquid chromatography system. The mass spectrometer was operated in a data-dependent SPS-MS3 mode in a top speed for 2 seconds. Full Scan was acquired at 120K resolution at 200 m/z measured using Orbitrap mass analyser in the scan range of 350-1500 m/z. The data dependent MS2 scans were isolated using quadrupole mass filter with 0.7 Th isolation width and fragmented using normalised 32% HCD and detected using an Ion trap mass analyser which was operated in a rapid mode.</p><p id="P39">Data analysis for mouse tissue: spinal cord raw MS data was searched with Fragpipe software suite (version: 19.1) [<xref ref-type="bibr" rid="R68">68</xref>] against the Uniprot Mouse database appended with (GA)400 sequences for C9orf72 and a common contaminant list exists within Fragpipe. FDR was set at 1% for both protein and PSM level. The protein group output files were further processed using Perseus software suite (version: 1.6.15.0) [<xref ref-type="bibr" rid="R70">70</xref>] for downstream statistical analysis. Two-sided Welch's t-Test with 5% FDR multiple-correction was performed to identify differentially regulated proteins. Gene-Ontology analysis was performed on differentially regulated proteins using enrichR software [<xref ref-type="bibr" rid="R71">71</xref>].</p><p id="P40">Gene Ontology analysis was performed on differentially regulated proteins using the software R and the package enrichR [<xref ref-type="bibr" rid="R71">71</xref>], [<xref ref-type="bibr" rid="R72">72</xref>] (<ext-link ext-link-type="uri" xlink:href="https://ggplot2.tidyverse.org">https://ggplot2.tidyverse.org</ext-link>). We assessed the co-occurrence of significant genes from our proteomics analysis with those found to be co-immunoprecipitated with polyGA in two different works [<xref ref-type="bibr" rid="R9">9</xref>], [<xref ref-type="bibr" rid="R58">58</xref>], based on Drosophila melanogaster and Homo sapiens lines. First, we found mouse orthologues using DIOPT [<xref ref-type="bibr" rid="R73">73</xref>], [<xref ref-type="bibr" rid="R74">74</xref>], then we represented the co-occurring genes using the software R and the package ggplot2 [<xref ref-type="bibr" rid="R72">72</xref>] (<ext-link ext-link-type="uri" xlink:href="https://ggplot2.tidyverse.org">https://ggplot2.tidyverse.org</ext-link>).</p></sec><sec id="S18"><title>Statistical analysis</title><p id="P41">All data are presented as mean ± standard error of the mean (SEM). Statistical differences of continuous data from two experimental groups were calculated using unpaired two-sample Student's t-test. Comparisons of data from more than two groups were performed using a one-way-ANOVA followed by Bonferroni correction for multiple comparisons. When two independent variables were available, comparisons of data from more than two groups were performed using a two-way-ANOVA followed by Bonferroni correction for multiple comparisons. Data distribution was tested for normality using Kolmogorov-Smirnov test; when normality could not be tested, we assumed data distribution to be normal. Statistical significance threshold was set at P &lt; 0.05, unless otherwise indicated. Statistical methods were used to predetermine sample sizes.</p></sec><sec id="S19"><title>Data collection</title><p id="P42">Data collection and analysis were performed blind to the conditions of the experiments.</p></sec></sec><sec sec-type="supplementary-material" id="SM"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SD1"><label>Supplementary Figures</label><media xlink:href="EMS206142-supplement-Supplementary_Figures.pdf" mimetype="application" mime-subtype="pdf" id="d80aAcEbB" position="anchor"/></supplementary-material></sec></body><back><ack id="S20"><title>Acknowledgements</title><p>We thank the staff of the MRC Prion Unit at UCL Biological Services Facility; Nick Kaye, Craig Fitzhugh, Juliette Ajok-Omona, and Rebekah Hallpike for experimental assistance. We also thank the UK DRI at UCL technicians Elena Ghirardello and Phill Muckett, and the Biological Services Units at UCL.</p><p>This work was supported by the Motor Neuron Disease Association and the UK Dementia Research Institute through UK DRI Ltd, principally funded by the Medical Research Council</p></ack><sec id="S21" sec-type="data-availability"><title>Data Availability</title><p id="P43">The datasets generated and analysed during the present study are available from the corresponding authors upon request.</p><p id="P44">Proteomics data from cortex and spinal cord, MS raw data and search output files have been deposited to the PRIDE ProteomeXchange Consortium via the PRIDE partner repository with the dataset identifier PXD047502.</p></sec><fn-group><fn id="FN1" fn-type="con"><p id="P45"><bold>Author Contributions Statement</bold></p><p id="P46">Design of the study and conceptualization: C.M., E.M.C.F., and A.M.I. Experiments and data generation: C.M., M.C., M.Z, M.A., R.S.N, D.B., E.K., I.G., A.S. Supervised research: A.D., P.F., D.R.A., B.D., L.G. Writing of the original and revised draft: C.M., E.M.C.F., and A.M.I. All authors read and approved the manuscript.</p></fn><fn id="FN2" fn-type="conflict"><p id="P47"><bold>Competing Interests Statement</bold></p><p id="P48">The authors declare no competing interests.</p></fn></fn-group><ref-list><ref id="R1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeJesus-Hernandez</surname><given-names>M</given-names></name><etal/></person-group><article-title>Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS</article-title><source>Neuron</source><year>2011</year><month>Oct</month><volume>72</volume><issue>2</issue><fpage>245</fpage><lpage>256</lpage><pub-id pub-id-type="pmcid">PMC3202986</pub-id><pub-id pub-id-type="pmid">21944778</pub-id><pub-id pub-id-type="doi">10.1016/j.neuron.2011.09.011</pub-id></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Renton</surname><given-names>AE</given-names></name><etal/></person-group><article-title>A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD</article-title><source>Neuron</source><year>2011</year><month>Oct</month><volume>72</volume><issue>2</issue><fpage>257</fpage><lpage>268</lpage><pub-id pub-id-type="pmcid">PMC3200438</pub-id><pub-id pub-id-type="pmid">21944779</pub-id><pub-id pub-id-type="doi">10.1016/j.neuron.2011.09.010</pub-id></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mizielinska</surname><given-names>S</given-names></name><etal/></person-group><article-title>Amyotrophic lateral sclerosis caused by hexanucleotide repeat expansions in C9orf72: from genetics to therapeutics</article-title><source>Lancet Neurol</source><year>2025</year><month>Mar</month><volume>24</volume><issue>3</issue><fpage>261</fpage><lpage>274</lpage><pub-id pub-id-type="pmcid">PMC12010636</pub-id><pub-id pub-id-type="pmid">39986312</pub-id><pub-id pub-id-type="doi">10.1016/S1474-4422(25)00026-2</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balendra</surname><given-names>R</given-names></name><name><surname>Isaacs</surname><given-names>AM</given-names></name></person-group><article-title>C9orf72-mediated ALS and FTD: multiple pathways to disease</article-title><source>Nat Rev Neurol</source><year>2018</year><month>Sep</month><volume>14</volume><issue>9</issue><fpage>544</fpage><lpage>558</lpage><pub-id pub-id-type="pmcid">PMC6417666</pub-id><pub-id pub-id-type="pmid">30120348</pub-id><pub-id pub-id-type="doi">10.1038/s41582-018-0047-2</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zu</surname><given-names>T</given-names></name><etal/></person-group><article-title>Non-ATG-initiated translation directed by microsatellite expansions</article-title><source>Proc Natl Acad Sci U S A</source><year>2011</year><month>Jan</month><volume>108</volume><issue>1</issue><fpage>260</fpage><lpage>265</lpage><pub-id pub-id-type="pmcid">PMC3017129</pub-id><pub-id pub-id-type="pmid">21173221</pub-id><pub-id pub-id-type="doi">10.1073/pnas.1013343108</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ash</surname><given-names>EAP</given-names></name><etal/></person-group><article-title>Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS</article-title><source>Neuron</source><year>2013</year><month>Feb</month><volume>77</volume><issue>4</issue><fpage>639</fpage><lpage>646</lpage><pub-id pub-id-type="pmcid">PMC3593233</pub-id><pub-id pub-id-type="pmid">23415312</pub-id><pub-id pub-id-type="doi">10.1016/j.neuron.2013.02.004</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mori</surname><given-names>K</given-names></name><etal/></person-group><article-title>The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS</article-title><source>Science</source><year>2013</year><month>Mar</month><volume>339</volume><issue>6125</issue><fpage>1335</fpage><lpage>1338</lpage><pub-id pub-id-type="pmid">23393093</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmitz</surname><given-names>A</given-names></name><name><surname>Pinheiro Marques</surname><given-names>J</given-names></name><name><surname>Oertig</surname><given-names>I</given-names></name><name><surname>Maharjan</surname><given-names>N</given-names></name><name><surname>Saxena</surname><given-names>S</given-names></name></person-group><article-title>Emerging Perspectives on Dipeptide Repeat Proteins in C9ORF72 ALS/FTD</article-title><source>Front Cell Neurosci</source><year>2021</year><month>Feb</month><volume>15</volume><pub-id pub-id-type="pmcid">PMC7930069</pub-id><pub-id pub-id-type="pmid">33679328</pub-id><pub-id pub-id-type="doi">10.3389/fncel.2021.637548</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bozič</surname><given-names>J</given-names></name><etal/></person-group><article-title>Interactome screening of C9orf72 dipeptide repeats reveals VCP sequestration and functional impairment by polyGA</article-title><source>Brain</source><year>2022</year><month>Apr</month><volume>145</volume><issue>2</issue><fpage>684</fpage><lpage>699</lpage><pub-id pub-id-type="pmcid">PMC9014755</pub-id><pub-id pub-id-type="pmid">34534264</pub-id><pub-id pub-id-type="doi">10.1093/brain/awab300</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mizielinska</surname><given-names>S</given-names></name><etal/></person-group><article-title>C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteins</article-title><source>Science (80-)</source><year>2014</year><month>Sep</month><volume>6201</volume><fpage>1192</fpage><lpage>1194</lpage><pub-id pub-id-type="pmcid">PMC4944841</pub-id><pub-id pub-id-type="pmid">25103406</pub-id><pub-id pub-id-type="doi">10.1126/science.1256800</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwon</surname><given-names>I</given-names></name><etal/></person-group><article-title>Poly-dipeptides encoded by the C9orf72 repeats bind nucleoli, impede RNA biogenesis, and kill cells</article-title><source>Science</source><year>2014</year><month>Sep</month><volume>345</volume><issue>6201</issue><fpage>1139</fpage><lpage>1145</lpage><pub-id pub-id-type="pmcid">PMC4459787</pub-id><pub-id pub-id-type="pmid">25081482</pub-id><pub-id pub-id-type="doi">10.1126/science.1254917</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wen</surname><given-names>X</given-names></name><etal/></person-group><article-title>Antisense proline-arginine RAN dipeptides linked to C9ORF72-ALS/FTD form toxic nuclear aggregates that initiate in vitro and in vivo neuronal death</article-title><source>Neuron</source><year>2014</year><month>Dec</month><volume>84</volume><issue>6</issue><fpage>1213</fpage><lpage>1225</lpage><pub-id pub-id-type="pmcid">PMC4632245</pub-id><pub-id pub-id-type="pmid">25521377</pub-id><pub-id pub-id-type="doi">10.1016/j.neuron.2014.12.010</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>SY</given-names></name><etal/></person-group><article-title>C9ORF72-ALS/FTD-associated poly(GR) binds Atp5a1 and compromises mitochondrial function in vivo</article-title><source>Nat Neurosci</source><year>2019</year><month>Jun</month><volume>22</volume><issue>6</issue><fpage>851</fpage><lpage>862</lpage><pub-id pub-id-type="pmcid">PMC6800116</pub-id><pub-id pub-id-type="pmid">31086314</pub-id><pub-id pub-id-type="doi">10.1038/s41593-019-0397-0</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hao</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Motor dysfunction and neurodegeneration in a C9orf72 mouse line expressing poly-PR</article-title><source>Nat Commun</source><year>2019</year><month>Dec</month><volume>10</volume><issue>1</issue><pub-id pub-id-type="pmcid">PMC6606620</pub-id><pub-id pub-id-type="pmid">31266945</pub-id><pub-id pub-id-type="doi">10.1038/s41467-019-10956-w</pub-id></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verdone</surname><given-names>BM</given-names></name><etal/></person-group><article-title>A mouse model with widespread expression of the C9orf72-linked glycine-arginine dipeptide displays non-lethal ALS/FTD-like phenotypes</article-title><source>Sci Rep</source><year>2022</year><month>Dec</month><volume>12</volume><issue>1</issue><pub-id pub-id-type="pmcid">PMC8979946</pub-id><pub-id pub-id-type="pmid">35379876</pub-id><pub-id pub-id-type="doi">10.1038/s41598-022-09593-z</pub-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>YJ</given-names></name><etal/></person-group><article-title>Poly(GR) impairs protein translation and stress granule dynamics in C9orf72-associated frontotemporal dementia and amyotrophic lateral sclerosis</article-title><source>Nat Med</source><year>2018</year><month>Aug</month><volume>24</volume><issue>8</issue><fpage>1136</fpage><lpage>1142</lpage><pub-id pub-id-type="pmcid">PMC6520050</pub-id><pub-id pub-id-type="pmid">29942091</pub-id><pub-id pub-id-type="doi">10.1038/s41591-018-0071-1</pub-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y-J</given-names></name><etal/></person-group><article-title>Heterochromatin anomalies and double-stranded RNA accumulation underlie <italic>C9orf72</italic> poly(PR) toxicity</article-title><source>Science (80-)</source><year>2019</year><volume>363</volume><issue>6428</issue><elocation-id>eaav2606</elocation-id><pub-id pub-id-type="pmcid">PMC6524780</pub-id><pub-id pub-id-type="pmid">30765536</pub-id><pub-id pub-id-type="doi">10.1126/science.aav2606</pub-id></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacKenzie</surname><given-names>IR</given-names></name><etal/></person-group><article-title>Dipeptide repeat protein pathology in C9ORF72 mutation cases: clinico-pathological correlations</article-title><source>Acta Neuropathol</source><year>2013</year><month>Dec</month><volume>126</volume><issue>6</issue><fpage>859</fpage><lpage>879</lpage><pub-id pub-id-type="pmid">24096617</pub-id></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mackenzie</surname><given-names>RAI</given-names></name><etal/></person-group><article-title>Quantitative analysis and clinico-pathological correlations of different dipeptide repeat protein pathologies in C9ORF72 mutation carriers</article-title><source>Acta Neuropathol</source><year>2015</year><volume>130</volume><issue>6</issue><fpage>845</fpage><lpage>861</lpage><pub-id pub-id-type="pmid">26374446</pub-id></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schludi</surname><given-names>MH</given-names></name><etal/></person-group><article-title>Distribution of dipeptide repeat proteins in cellular models and C9orf72 mutation cases suggests link to transcriptional silencing</article-title><source>Acta Neuropathol</source><year>2015</year><month>Oct</month><volume>130</volume><issue>4</issue><fpage>537</fpage><lpage>555</lpage><pub-id pub-id-type="pmcid">PMC4575390</pub-id><pub-id pub-id-type="pmid">26085200</pub-id><pub-id pub-id-type="doi">10.1007/s00401-015-1450-z</pub-id></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>YJ</given-names></name><etal/></person-group><article-title>Aggregation-prone c9FTD/ALS poly(GA) RAN-translated proteins cause neurotoxicity by inducing ER stress</article-title><source>Acta Neuropathol</source><year>2014</year><volume>128</volume><issue>4</issue><fpage>505</fpage><lpage>524</lpage><pub-id pub-id-type="pmcid">PMC4159567</pub-id><pub-id pub-id-type="pmid">25173361</pub-id><pub-id pub-id-type="doi">10.1007/s00401-014-1336-5</pub-id></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khosravi</surname><given-names>B</given-names></name><etal/></person-group><article-title>Cell-to-cell transmission of C9orf72 poly-(Gly-Ala) triggers key features of ALS / FTD</article-title><source>EMBO J</source><year>2020</year><month>Apr</month><volume>39</volume><issue>8</issue><pub-id pub-id-type="pmcid">PMC7156967</pub-id><pub-id pub-id-type="pmid">32175624</pub-id><pub-id pub-id-type="doi">10.15252/embj.2019102811</pub-id></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nonaka</surname><given-names>T</given-names></name><etal/></person-group><article-title>C9ORF72 dipeptide repeat poly-GA inclusions promote intracellular aggregation of phosphorylated TDP-43</article-title><source>Hum Mol Genet</source><year>2018</year><month>Aug</month><volume>27</volume><issue>15</issue><fpage>2658</fpage><lpage>2670</lpage><pub-id pub-id-type="pmid">29750243</pub-id></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khosravi</surname><given-names>B</given-names></name><etal/></person-group><article-title>Cytoplasmic poly-GA aggregates impair nuclear import of TDP-43 in C9orf72 ALS/FTLD</article-title><source>Hum Mol Genet</source><year>2017</year><month>Feb</month><volume>26</volume><issue>4</issue><fpage>790</fpage><lpage>800</lpage><pub-id pub-id-type="pmcid">PMC5409121</pub-id><pub-id pub-id-type="pmid">28040728</pub-id><pub-id pub-id-type="doi">10.1093/hmg/ddw432</pub-id></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steffke</surname><given-names>C</given-names></name><name><surname>Agarwal</surname><given-names>S</given-names></name><name><surname>Kabashi</surname><given-names>E</given-names></name><name><surname>Catanese</surname><given-names>A</given-names></name></person-group><article-title>Overexpression of Toxic Poly(Glycine-Alanine) Aggregates in Primary Neuronal Cultures Induces Time-Dependent Autophagic and Synaptic Alterations but Subtle Activity Impairments</article-title><source>Cells</source><year>2024</year><month>Aug</month><volume>13</volume><issue>15</issue><pub-id pub-id-type="pmcid">PMC11311834</pub-id><pub-id pub-id-type="pmid">39120329</pub-id><pub-id pub-id-type="doi">10.3390/cells13151300</pub-id></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>F</given-names></name><etal/></person-group><article-title>Proximity proteomics of C9orf72 dipeptide repeat proteins identifies molecular chaperones as modifiers of poly-GA aggregation</article-title><source>Acta Neuropathol Commun</source><year>2022</year><month>Dec</month><volume>10</volume><issue>1</issue><fpage>22</fpage><pub-id pub-id-type="pmcid">PMC8842533</pub-id><pub-id pub-id-type="pmid">35164882</pub-id><pub-id pub-id-type="doi">10.1186/s40478-022-01322-x</pub-id></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pilotto</surname><given-names>F</given-names></name><etal/></person-group><article-title>PolyGA targets the ER stress-adaptive response by impairing GRP75 function at the MAM in C9ORF72-ALS/FTD</article-title><source>Acta Neuropathol</source><year>2022</year><month>Nov</month><volume>144</volume><issue>5</issue><fpage>939</fpage><lpage>966</lpage><pub-id pub-id-type="pmcid">PMC9547809</pub-id><pub-id pub-id-type="pmid">36121477</pub-id><pub-id pub-id-type="doi">10.1007/s00401-022-02494-5</pub-id></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>Q</given-names></name><etal/></person-group><article-title>In Situ Structure of Neuronal C9orf72 Poly-GA Aggregates Reveals Proteasome Recruitment</article-title><source>Cell</source><year>2018</year><month>Feb</month><volume>172</volume><issue>4</issue><fpage>696</fpage><lpage>705</lpage><elocation-id>e12</elocation-id><pub-id pub-id-type="pmcid">PMC6035389</pub-id><pub-id pub-id-type="pmid">29398115</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2017.12.030</pub-id></element-citation></ref><ref id="R29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y-J</given-names></name><etal/></person-group><article-title>C9ORF72 poly(GA) aggregates sequester and impair HR23 and nucleocytoplasmic transport proteins</article-title><source>Nat Neurosci</source><year>2016</year><volume>19</volume><issue>5</issue><fpage>668</fpage><lpage>677</lpage><pub-id pub-id-type="pmcid">PMC5138863</pub-id><pub-id pub-id-type="pmid">26998601</pub-id><pub-id pub-id-type="doi">10.1038/nn.4272</pub-id></element-citation></ref><ref id="R30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moens</surname><given-names>TG</given-names></name><name><surname>Partridge</surname><given-names>L</given-names></name><name><surname>Isaacs</surname><given-names>AM</given-names></name></person-group><article-title>Genetic models of C9orf72: what is toxic?</article-title><source>Curr Opin Genet Dev</source><year>2017</year><volume>44</volume><fpage>92</fpage><lpage>101</lpage><pub-id pub-id-type="pmid">28364657</pub-id></element-citation></ref><ref id="R31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Todd</surname><given-names>TW</given-names></name><name><surname>Petrucelli</surname><given-names>L</given-names></name></person-group><article-title>Modelling amyotrophic lateral sclerosis in rodents</article-title><source>Nat Rev Neurosci</source><year>2022</year><month>Mar</month><fpage>1</fpage><lpage>21</lpage><comment>2022</comment><pub-id pub-id-type="pmid">35260846</pub-id></element-citation></ref><ref id="R32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Rourke</surname><given-names>JG</given-names></name><etal/></person-group><article-title>C9orf72 is required for proper macrophage and microglial function in mice</article-title><source>Science</source><year>2016</year><month>Mar</month><volume>351</volume><issue>6279</issue><fpage>1324</fpage><lpage>1329</lpage><pub-id pub-id-type="pmcid">PMC5120541</pub-id><pub-id pub-id-type="pmid">26989253</pub-id><pub-id pub-id-type="doi">10.1126/science.aaf1064</pub-id></element-citation></ref><ref id="R33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burberry</surname><given-names>A</given-names></name><etal/></person-group><article-title>Loss-of-function mutations in the C9ORF72 mouse ortholog cause fatal autoimmune disease</article-title><source>Sci Transl Med</source><year>2016</year><month>Jul</month><volume>8</volume><issue>347</issue><pub-id pub-id-type="pmcid">PMC5024536</pub-id><pub-id pub-id-type="pmid">27412785</pub-id><pub-id pub-id-type="doi">10.1126/scitranslmed.aaf6038</pub-id></element-citation></ref><ref id="R34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atanasio</surname><given-names>A</given-names></name><etal/></person-group><article-title>C9orf72 ablation causes immune dysregulation characterized by leukocyte expansion, autoantibody production, and glomerulonephropathy in mice</article-title><source>Sci Rep</source><year>2016</year><volume>6</volume><elocation-id>23204</elocation-id><comment>November 2015</comment><pub-id pub-id-type="pmcid">PMC4793236</pub-id><pub-id pub-id-type="pmid">26979938</pub-id><pub-id pub-id-type="doi">10.1038/srep23204</pub-id></element-citation></ref><ref id="R35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>J</given-names></name><etal/></person-group><article-title>Gain of Toxicity from ALS/FTD-Linked Repeat Expansions in C9ORF72 Is Alleviated by Antisense Oligonucleotides Targeting GGGGCC-Containing RNAs</article-title><source>Neuron</source><year>2016</year><month>May</month><volume>90</volume><issue>3</issue><fpage>535</fpage><lpage>550</lpage><pub-id pub-id-type="pmcid">PMC4860075</pub-id><pub-id pub-id-type="pmid">27112497</pub-id><pub-id pub-id-type="doi">10.1016/j.neuron.2016.04.006</pub-id></element-citation></ref><ref id="R36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burberry</surname><given-names>A</given-names></name><etal/></person-group><article-title>C9orf72 suppresses systemic and neural inflammation induced by gut bacteria</article-title><source>Nature</source><year>2020</year><month>May</month><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="pmcid">PMC7416879</pub-id><pub-id pub-id-type="pmid">32483373</pub-id><pub-id pub-id-type="doi">10.1038/s41586-020-2288-7</pub-id></element-citation></ref><ref id="R37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koppers</surname><given-names>M</given-names></name><etal/></person-group><article-title>C9orf72 ablation in mice does not cause motor neuron degeneration or motor deficits</article-title><source>Ann Neurol</source><year>2015</year><month>Sep</month><volume>78</volume><issue>3</issue><fpage>426</fpage><lpage>438</lpage><pub-id pub-id-type="pmcid">PMC4744979</pub-id><pub-id pub-id-type="pmid">26044557</pub-id><pub-id pub-id-type="doi">10.1002/ana.24453</pub-id></element-citation></ref><ref id="R38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sullivan</surname><given-names>PM</given-names></name><etal/></person-group><article-title>The ALS/FTLD associated protein C9orf72 associates with SMCR8 and WDR41 to regulate the autophagy-lysosome pathway</article-title><source>Acta Neuropathol Commun</source><year>2016</year><month>May</month><volume>4</volume><issue>1</issue><fpage>51</fpage><pub-id pub-id-type="pmcid">PMC4870812</pub-id><pub-id pub-id-type="pmid">27193190</pub-id><pub-id pub-id-type="doi">10.1186/s40478-016-0324-5</pub-id></element-citation></ref><ref id="R39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sudria-Lopez</surname><given-names>E</given-names></name><etal/></person-group><article-title>Full ablation of C9orf72 in mice causes immune system-related pathology and neoplastic events but no motor neuron defects</article-title><source>Acta Neuropathol</source><year>2016</year><month>Jul</month><volume>132</volume><issue>1</issue><fpage>145</fpage><lpage>147</lpage><pub-id pub-id-type="pmcid">PMC4911370</pub-id><pub-id pub-id-type="pmid">27206760</pub-id><pub-id pub-id-type="doi">10.1007/s00401-016-1581-x</pub-id></element-citation></ref><ref id="R40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chew</surname><given-names>J</given-names></name><etal/></person-group><article-title>Neurodegeneration C9ORF72 repeat expansions in mice cause TDP-43 pathology, neuronal loss, and behavioral deficits</article-title><source>Science</source><year>2015</year><volume>348</volume><issue>6239</issue><fpage>1151</fpage><lpage>4</lpage><pub-id pub-id-type="pmcid">PMC4692360</pub-id><pub-id pub-id-type="pmid">25977373</pub-id><pub-id pub-id-type="doi">10.1126/science.aaa9344</pub-id></element-citation></ref><ref id="R41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chew</surname><given-names>J</given-names></name><etal/></person-group><article-title>Aberrant deposition of stress granule-resident proteins linked to C9orf72-associated TDP-43 proteinopathy</article-title><source>Mol Neurodegener</source><year>2019</year><volume>14</volume><issue>1</issue><fpage>9</fpage><pub-id pub-id-type="pmcid">PMC6377782</pub-id><pub-id pub-id-type="pmid">30767771</pub-id><pub-id pub-id-type="doi">10.1186/s13024-019-0310-z</pub-id></element-citation></ref><ref id="R42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>J</given-names></name><etal/></person-group><article-title>Gain of Toxicity from ALS/FTD-Linked Repeat Expansions in C9ORF72 Is Alleviated by Antisense Oligonucleotides Targeting GGGGCC-Containing RNAs</article-title><source>Neuron</source><year>2016</year><month>May</month><volume>90</volume><issue>3</issue><fpage>535</fpage><lpage>550</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2016.04.006</pub-id></element-citation></ref><ref id="R43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Rourke</surname><given-names>JG</given-names></name><etal/></person-group><article-title>C9orf72 BAC Transgenic Mice Display Typical Pathologic Features of ALS/FTD</article-title><source>Neuron</source><year>2015</year><volume>88</volume><issue>5</issue><fpage>892</fpage><lpage>901</lpage><pub-id pub-id-type="pmcid">PMC4672384</pub-id><pub-id pub-id-type="pmid">26637796</pub-id><pub-id pub-id-type="doi">10.1016/j.neuron.2015.10.027</pub-id></element-citation></ref><ref id="R44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peters</surname><given-names>OM</given-names></name><etal/></person-group><article-title>Human C9ORF72 Hexanucleotide Expansion Reproduces RNA Foci and Dipeptide Repeat Proteins but Not Neurodegeneration in BAC Transgenic Mice</article-title><source>Neuron</source><year>2015</year><month>Dec</month><volume>88</volume><issue>5</issue><fpage>902</fpage><lpage>909</lpage><pub-id pub-id-type="pmcid">PMC4828340</pub-id><pub-id pub-id-type="pmid">26637797</pub-id><pub-id pub-id-type="doi">10.1016/j.neuron.2015.11.018</pub-id></element-citation></ref><ref id="R45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><etal/></person-group><article-title>C9orf72 BAC Mouse Model with Motor Deficits and Neurodegenerative Features of ALS/FTD</article-title><source>Neuron</source><year>2016</year><month>May</month><volume>90</volume><issue>3</issue><fpage>521</fpage><lpage>534</lpage><pub-id pub-id-type="pmid">27112499</pub-id></element-citation></ref><ref id="R46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Giorgio</surname><given-names>F</given-names></name><name><surname>Maduro</surname><given-names>C</given-names></name><name><surname>Fisher</surname><given-names>MCE</given-names></name><name><surname>Acevedo-Arozena</surname><given-names>A</given-names></name></person-group><article-title>Transgenic and physiological mouse models give insights into different aspects of amyotrophic lateral sclerosis</article-title><source>DMM Dis Model Mech</source><year>2019</year><volume>12</volume><issue>1</issue><pub-id pub-id-type="pmcid">PMC6361152</pub-id><pub-id pub-id-type="pmid">30626575</pub-id><pub-id pub-id-type="doi">10.1242/dmm.037424</pub-id></element-citation></ref><ref id="R47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cook</surname><given-names>CN</given-names></name><etal/></person-group><article-title>C9orf72 poly(GR) aggregation induces TDP-43 proteinopathy</article-title><source>Sci Transl Med</source><year>2020</year><volume>12</volume><issue>559</issue><pub-id pub-id-type="pmcid">PMC7989020</pub-id><pub-id pub-id-type="pmid">32878979</pub-id><pub-id pub-id-type="doi">10.1126/scitranslmed.abb3774</pub-id></element-citation></ref><ref id="R48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schludi</surname><given-names>MH</given-names></name><etal/></person-group><article-title>Spinal poly-GA inclusions in a C9orf72 mouse model trigger motor deficits and inflammation without neuron loss</article-title><source>Acta Neuropathol</source><year>2017</year><month>Aug</month><volume>134</volume><issue>2</issue><fpage>241</fpage><lpage>254</lpage><pub-id pub-id-type="pmcid">PMC5508040</pub-id><pub-id pub-id-type="pmid">28409281</pub-id><pub-id pub-id-type="doi">10.1007/s00401-017-1711-0</pub-id></element-citation></ref><ref id="R49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>LaClair</surname><given-names>KD</given-names></name><etal/></person-group><article-title>Congenic expression of poly-GA but not poly-PR in mice triggers selective neuron loss and interferon responses found in C9orf72 ALS</article-title><source>Acta Neuropathol</source><year>2020</year><month>Jun</month><pub-id pub-id-type="pmcid">PMC7360660</pub-id><pub-id pub-id-type="pmid">32562018</pub-id><pub-id pub-id-type="doi">10.1007/s00401-020-02176-0</pub-id></element-citation></ref><ref id="R50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>Q</given-names></name><etal/></person-group><article-title>Active poly-GA vaccination prevents microglia activation and motor deficits in a C9orf72 mouse model</article-title><source>EMBO Mol Med</source><year>2020</year><month>Feb</month><volume>12</volume><issue>2</issue><pub-id pub-id-type="pmcid">PMC7005532</pub-id><pub-id pub-id-type="pmid">31858749</pub-id><pub-id pub-id-type="doi">10.15252/emmm.201910919</pub-id></element-citation></ref><ref id="R51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>Q</given-names></name><etal/></person-group><article-title>Antibodies inhibit transmission and aggregation of C9orf72 poly-GA dipeptide repeat proteins</article-title><source>EMBO Mol Med</source><year>2017</year><month>May</month><volume>9</volume><issue>5</issue><fpage>687</fpage><lpage>702</lpage><pub-id pub-id-type="pmcid">PMC5412769</pub-id><pub-id pub-id-type="pmid">28351931</pub-id><pub-id pub-id-type="doi">10.15252/emmm.201607054</pub-id></element-citation></ref><ref id="R52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>L</given-names></name><etal/></person-group><article-title>Antibody Therapy Targeting RAN Proteins Rescues C9 ALS/FTD Phenotypes in C9orf72 Mouse Model</article-title><source>Neuron</source><year>2020</year><volume>105</volume><issue>4</issue><fpage>645</fpage><lpage>662</lpage><elocation-id>e11</elocation-id><pub-id pub-id-type="pmcid">PMC7391607</pub-id><pub-id pub-id-type="pmid">31831332</pub-id><pub-id pub-id-type="doi">10.1016/j.neuron.2019.11.007</pub-id></element-citation></ref><ref id="R53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jambeau</surname><given-names>M</given-names></name><etal/></person-group><article-title>Comprehensive evaluation of human-derived anti-poly-GA antibodies in cellular and animal models of C9orf72 disease</article-title><source>Proc Natl Acad Sci U S A</source><year>2022</year><month>Dec</month><volume>119</volume><issue>49</issue><pub-id pub-id-type="pmcid">PMC9894253</pub-id><pub-id pub-id-type="pmid">36454749</pub-id><pub-id pub-id-type="doi">10.1073/pnas.2123487119</pub-id></element-citation></ref><ref id="R54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>F</given-names></name><name><surname>Almeida</surname><given-names>S</given-names></name><name><surname>Lopez-Gonzalez</surname><given-names>R</given-names></name></person-group><article-title>Dysregulated molecular pathways in amyotrophic lateral sclerosis-frontotemporal dementia spectrum disorder</article-title><source>EMBO J</source><year>2017</year><month>Oct</month><volume>36</volume><issue>20</issue><fpage>2931</fpage><lpage>2950</lpage><pub-id pub-id-type="pmcid">PMC5641681</pub-id><pub-id pub-id-type="pmid">28916614</pub-id><pub-id pub-id-type="doi">10.15252/embj.201797568</pub-id></element-citation></ref><ref id="R55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coyne</surname><given-names>AN</given-names></name><etal/></person-group><article-title>G4C2 Repeat RNA Initiates a POM121-Mediated Reduction in Specific Nucleoporins in C9orf72 ALS/FTD</article-title><source>Neuron</source><year>2020</year><month>Sep</month><volume>107</volume><issue>6</issue><fpage>1124</fpage><lpage>1140</lpage><elocation-id>e11</elocation-id><pub-id pub-id-type="pmcid">PMC8077944</pub-id><pub-id pub-id-type="pmid">32673563</pub-id><pub-id pub-id-type="doi">10.1016/j.neuron.2020.06.027</pub-id></element-citation></ref><ref id="R56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghaffari</surname><given-names>LT</given-names></name><name><surname>Trotti</surname><given-names>D</given-names></name><name><surname>Haeusler</surname><given-names>AR</given-names></name><name><surname>Jensen</surname><given-names>BK</given-names></name></person-group><article-title>Breakdown of the central synapses in C9orf72-linked ALS/FTD</article-title><source>Front Mol Neurosci</source><year>2022</year><month>Sep</month><volume>15</volume><pub-id pub-id-type="pmcid">PMC9523884</pub-id><pub-id pub-id-type="pmid">36187344</pub-id><pub-id pub-id-type="doi">10.3389/fnmol.2022.1005112</pub-id></element-citation></ref><ref id="R57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giblin</surname><given-names>A</given-names></name><etal/></person-group><article-title>Author Correction: Neuronal polyunsaturated fatty acids are protective in ALS/FTD</article-title><source>Nat Neurosci</source><year>2025</year><month>Apr</month><volume>28</volume><issue>4</issue><fpage>913</fpage><pub-id pub-id-type="pmcid">PMC11976256</pub-id><pub-id pub-id-type="pmid">40055545</pub-id><pub-id pub-id-type="doi">10.1038/s41593-025-01926-1</pub-id></element-citation></ref><ref id="R58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moens</surname><given-names>TG</given-names></name><etal/></person-group><article-title>C9orf72 arginine-rich dipeptide proteins interact with ribosomal proteins in vivo to induce a toxic translational arrest that is rescued by eIF1A</article-title><source>Acta Neuropathol</source><year>2019</year><month>Mar</month><volume>137</volume><issue>3</issue><fpage>487</fpage><lpage>500</lpage><pub-id pub-id-type="pmcid">PMC6514073</pub-id><pub-id pub-id-type="pmid">30604225</pub-id><pub-id pub-id-type="doi">10.1007/s00401-018-1946-4</pub-id></element-citation></ref><ref id="R59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Milioto</surname><given-names>C</given-names></name><etal/></person-group><article-title>PolyGR and polyPR knock-in mice reveal a conserved neuroprotective extracellular matrix signature in C9orf72 ALS/FTD neurons</article-title><source>Nat Neurosci</source><year>2024</year><month>Feb</month><fpage>1</fpage><lpage>13</lpage><comment>2024</comment><pub-id pub-id-type="pmcid">PMC11001582</pub-id><pub-id pub-id-type="pmid">38424324</pub-id><pub-id pub-id-type="doi">10.1038/s41593-024-01589-4</pub-id></element-citation></ref><ref id="R60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meyer</surname><given-names>DE</given-names></name><name><surname>Chilkoti</surname><given-names>A</given-names></name></person-group><article-title>Genetically encoded synthesis of protein-based polymers with precisely specified molecular weight and sequence by recursive directional ligation: examples from the elastin-like polypeptide system</article-title><source>Biomacromolecules</source><year>2002</year><volume>3</volume><issue>2</issue><fpage>357</fpage><lpage>367</lpage><pub-id pub-id-type="pmid">11888323</pub-id></element-citation></ref><ref id="R61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coyne</surname><given-names>AN</given-names></name><etal/></person-group><article-title>Post-transcriptional Inhibition of Hsc70-4/HSPA8 Expression Leads to Synaptic Vesicle Cycling Defects in Multiple Models of ALS</article-title><source>Cell Rep</source><year>2017</year><month>Oct</month><volume>21</volume><issue>1</issue><fpage>110</fpage><lpage>125</lpage><pub-id pub-id-type="pmcid">PMC5679478</pub-id><pub-id pub-id-type="pmid">28978466</pub-id><pub-id pub-id-type="doi">10.1016/j.celrep.2017.09.028</pub-id></element-citation></ref><ref id="R62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Solomon</surname><given-names>DA</given-names></name><etal/></person-group><article-title>A feedback loop between dipeptide-repeat protein, TDP-43 and karyopherin-a mediates C9orf72-related neurodegeneration</article-title><source>Brain</source><year>2018</year><month>Oct</month><volume>141</volume><issue>10</issue><fpage>2908</fpage><lpage>2924</lpage><pub-id pub-id-type="pmcid">PMC6158706</pub-id><pub-id pub-id-type="pmid">30239641</pub-id><pub-id pub-id-type="doi">10.1093/brain/awy241</pub-id></element-citation></ref><ref id="R63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simone</surname><given-names>R</given-names></name><etal/></person-group><article-title>G-quadruplex-binding small molecules ameliorate C9orf72 FTD/ALS pathology in vitro and in vivo</article-title><source>EMBO Mol Med</source><year>2018</year><month>Jan</month><volume>10</volume><issue>1</issue><fpage>22</fpage><lpage>31</lpage><pub-id pub-id-type="pmcid">PMC5760849</pub-id><pub-id pub-id-type="pmid">29113975</pub-id><pub-id pub-id-type="doi">10.15252/emmm.201707850</pub-id></element-citation></ref><ref id="R64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moens</surname><given-names>TG</given-names></name><etal/></person-group><article-title>Sense and antisense RNA are not toxic in Drosophila models of C9orf72-associated ALS/FTD</article-title><source>Acta Neuropathol</source><year>2018</year><month>Mar</month><volume>135</volume><issue>3</issue><fpage>445</fpage><lpage>457</lpage><pub-id pub-id-type="pmcid">PMC6385858</pub-id><pub-id pub-id-type="pmid">29380049</pub-id><pub-id pub-id-type="doi">10.1007/s00401-017-1798-3</pub-id></element-citation></ref><ref id="R65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quaegebeur</surname><given-names>A</given-names></name><name><surname>Glaria</surname><given-names>I</given-names></name><name><surname>Lashley</surname><given-names>T</given-names></name><name><surname>Isaacs</surname><given-names>AM</given-names></name></person-group><article-title>Soluble and insoluble dipeptide repeat protein measurements in C9orf72-frontotemporal dementia brains show regional differential solubility and correlation of poly-GR with clinical severity</article-title><source>Acta Neuropathol Commun</source><year>2020</year><month>Nov</month><volume>8</volume><issue>1</issue><fpage>184</fpage><pub-id pub-id-type="pmcid">PMC7650212</pub-id><pub-id pub-id-type="pmid">33168090</pub-id><pub-id pub-id-type="doi">10.1186/s40478-020-01036-y</pub-id></element-citation></ref><ref id="R66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmed</surname><given-names>M</given-names></name><etal/></person-group><article-title>Targeting protein homeostasis in sporadic inclusion body myositis</article-title><source>Sci Transl Med Mar</source><year>2016</year><volume>8</volume><issue>331</issue><pub-id pub-id-type="pmcid">PMC5043094</pub-id><pub-id pub-id-type="pmid">27009270</pub-id><pub-id pub-id-type="doi">10.1126/scitranslmed.aad4583</pub-id></element-citation></ref><ref id="R67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gray</surname><given-names>AL</given-names></name><etal/></person-group><article-title>Deterioration of muscle force and contractile characteristics are early pathological events in spinal and bulbar muscular atrophy mice</article-title><source>Dis Model Mech</source><year>2020</year><month>May</month><volume>13</volume><issue>5</issue><pub-id pub-id-type="pmcid">PMC7272358</pub-id><pub-id pub-id-type="pmid">32152060</pub-id><pub-id pub-id-type="doi">10.1242/dmm.042424</pub-id></element-citation></ref><ref id="R68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kong</surname><given-names>AT</given-names></name><name><surname>Leprevost</surname><given-names>FV</given-names></name><name><surname>Avtonomov</surname><given-names>DM</given-names></name><name><surname>Mellacheruvu</surname><given-names>D</given-names></name><name><surname>Nesvizhskii</surname><given-names>AI</given-names></name></person-group><article-title>MSFragger: Ultrafast and comprehensive peptide identification in mass spectrometry-based proteomics</article-title><source>Nat Methods</source><year>2017</year><month>Apr</month><volume>14</volume><issue>5</issue><fpage>513</fpage><lpage>520</lpage><pub-id pub-id-type="pmcid">PMC5409104</pub-id><pub-id pub-id-type="pmid">28394336</pub-id><pub-id pub-id-type="doi">10.1038/nmeth.4256</pub-id></element-citation></ref><ref id="R69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cox</surname><given-names>J</given-names></name><name><surname>Mann</surname><given-names>M</given-names></name></person-group><article-title>MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification</article-title><source>Nat Biotechnol</source><year>2008</year><month>Dec</month><volume>26</volume><issue>12</issue><fpage>1367</fpage><lpage>1372</lpage><pub-id pub-id-type="pmid">19029910</pub-id></element-citation></ref><ref id="R70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tyanova</surname><given-names>S</given-names></name><etal/></person-group><article-title>The Perseus computational platform for comprehensive analysis of (prote)omics data</article-title><source>Nat Methods</source><year>2016</year><month>Aug</month><volume>13</volume><issue>9</issue><fpage>731</fpage><lpage>740</lpage><pub-id pub-id-type="pmid">27348712</pub-id></element-citation></ref><ref id="R71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuleshov</surname><given-names>MV</given-names></name><etal/></person-group><article-title>Enrichr: a comprehensive gene set enrichment analysis web server 2016 update</article-title><source>Nucleic Acids Res</source><year>2016</year><month>Jul</month><volume>44</volume><issue>W1</issue><fpage>W90</fpage><lpage>W97</lpage><pub-id pub-id-type="pmcid">PMC4987924</pub-id><pub-id pub-id-type="pmid">27141961</pub-id><pub-id pub-id-type="doi">10.1093/nar/gkw377</pub-id></element-citation></ref><ref id="R72"><label>72</label><element-citation publication-type="other"><person-group person-group-type="author"><name><surname>Wickham</surname><given-names>H</given-names></name></person-group><source>ggplot2</source><year>2016</year><pub-id pub-id-type="doi">10.1007/978-3-319-24277-4</pub-id></element-citation></ref><ref id="R73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>Y</given-names></name><etal/></person-group><article-title>An integrative approach to ortholog prediction for disease-focused and other functional studies</article-title><source>BMC Bioinformatics</source><year>2011</year><month>Aug</month><volume>12</volume><pub-id pub-id-type="pmcid">PMC3179972</pub-id><pub-id pub-id-type="pmid">21880147</pub-id><pub-id pub-id-type="doi">10.1186/1471-2105-12-357</pub-id></element-citation></ref><ref id="R74"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>Y</given-names></name><etal/></person-group><article-title>FlyRNAi.org–the database of the Drosophila RNAi screening center and transgenic RNAi project: 2021 update</article-title><source>Nucleic Acids Res</source><year>2020</year><month>Jan</month><volume>49</volume><issue>D1</issue><fpage>D908</fpage><pub-id pub-id-type="pmcid">PMC7778949</pub-id><pub-id pub-id-type="pmid">33104800</pub-id><pub-id pub-id-type="doi">10.1093/nar/gkaa936</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" position="float"><label>Figure 1</label><caption><title>Generation of C9orf72 polyGA knock-in mice.</title><p>(A) Targeting strategy to generate (GA)400 mice with the knock-in sequence inserted in exon 2 of mouse <italic>C9orf72</italic> immediately after, and in frame with, the endogenous ATG. Schematic shows the genomic region and the knock-in targeting construct. Exons are shown boxed, untranslated regions of exons are coloured grey with translated regions in yellow. The targeting construct (in purple) contains the knock-in sequence composed of a double HA-tag, 400 codon-optimised <italic>Ga</italic> repeats, a V5-tag, a stop codon, and a 120 bp polyA tail.</p><p>(B) Quantification of polyGA proteins in cortex (left panel) and spinal cord (right panel) of WT and (GA)400 mice at 12 months of age by Meso Scale Discovery (MSD) immunoassay. Graph, mean ± SEM, n = 5 mice per genotype, two-sided unpaired two-sample Student's t-test.</p><p>(C) qPCR analysis of <italic>C9orf72</italic> knock-in transgene transcript levels normalised to <italic>Gapdh</italic> in spinal cord of WT and (GA)400 mice at 12 months of age. Common primers in the HA-tag and upstream endogenous mouse sequence were used to enable direct comparison between all lines. Graph, mean ± SEM, n = 5 mice per genotype, two-sided unpaired two-sample Student's t-test.</p><p>(D) Western blotting analysis of C9orf72 protein levels in cortex of WT and (GA)400 mice at 12 months of age. GAPDH is shown as loading control. Graph, mean ± SEM, n = 5 mice per genotype, two-sided unpaired two-sample Student's t-test.</p><p>(E) Western blotting analysis of C9orf72 protein levels in spinal cord of WT and (GA)400 mice at 12 months of age. GAPDH is shown as loading control. Graph, mean ± SEM, n = 5 mice per genotype, two-sided unpaired two-sample Student's t-test.</p><p>(F) qPCR analysis of <italic>C9orf72</italic> transcript levels normalized to <italic>Gapdh</italic> in brain cortex of WT and (GA)400 at 9 months of age. Graph, mean ± s.e.m.; n = 3 mice per genotype; two-sided unpaired two-sample Student's t-test.</p></caption><graphic xlink:href="EMS206142-f001"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><title>(GA)400 mice develop mild motor dysfunction.</title><p>(A) Body weights of WT and (GA)400 male (left panel) and female (right panel) mice up to 18 months of age. Graph, mean ± SEM, n = 14 mice per genotype, two-way ANOVA, Bonferroni's multiple comparison.</p><p>(B) Accelerated rotarod analysis of motor coordination in WT and (GA)400 male (left panel) and female (right panel) mice up to 18 months of age. Graph, mean ± SEM, n = 14 mice per genotype, two-way ANOVA, Bonferroni's multiple comparison.</p><p>(C) Grip strength analysis of muscle force in WT and (GA)400 male (left panel) and female (right panel) mice up to 18 months of age. Graph, mean ± SEM, n = 14 mice per genotype, two-way ANOVA, Bonferroni's multiple comparison.</p></caption><graphic xlink:href="EMS206142-f002"/></fig><fig id="F3" position="float"><label>Figure 3</label><caption><title>PolyGA expression causes modest age-dependent spinal motor neuron loss.</title><p>(A) Panel shows representative image of Nissl staining of lumbar spinal cord in WT and (GA)400 mice at 18 months of age; the purple line delineates the sciatic motor pool in which motor neurons were counted.</p><p>(B) Quantification of Nissl-stained motor neurons (MN) in lumbar spinal cord region L3-L5 in WT and (GA)400 mice at 9 months of age. Graph, mean ± SEM, n = 3-4 mice per genotype, two-sided unpaired two-sample Student's t-test.</p><p>(C) Quantification of Nissl-stained motor neurons in lumbar spinal cord region L3-L5 in WT and (GA)400 mice at 12 months of age. Graph, mean ± SEM, n = 5 mice per genotype, two-sided unpaired two-sample Student's t-test.</p><p>(D) Quantification of Nissl-stained motor neurons in lumbar spinal cord region L3-L5 in WT and (GA)400 mice at 18 months of age. Graph, mean ± SEM, n = 5 mice per genotype, two-sided unpaired two-sample Student's t-test.</p><p>(E) Representative confocal images and quantification of immunofluorescence staining showing microglial density and colocalization between microglial markers Iba1 (yellow) and microglial lysosomal marker CD68 (red) in lumbar spinal cord ventral horn in WT and (GA)400 mice at 18 months of age. Graph, mean ± SEM, n = 5 mice per genotype, two-sided unpaired two-sample Student's t-test.</p><p>(F) Representative confocal images and quantification of immunofluorescence staining of astrocytic marker GFAP (green) in lumbar spinal cord ventral horn in WT and (GA)400 mice at 18 months of age. DAPI (blue) stains nuclei. Graph, mean ± SEM, n = 5 mice per genotype, two-sided unpaired two-sample Student's t-test.</p></caption><graphic xlink:href="EMS206142-f003"/></fig><fig id="F4" position="float"><label>Figure 4</label><caption><title>PolyGA expression induces proteomic changes in the spinal cord.</title><p>(A) Protein expression volcano plots from the lumbar spinal cord of 12-month-old (GA)400. n = 5 mice per genotype, two-sided Welch's t-Test with 5% FDR multiple-correction.</p><p>(B) Significantly enriched downregulated (left) and upregulated (right) Gene Ontology (GO) pathways in the lumbar spinal cord of 12-month-old (GA)400 mice. Proteomics performed on n = 5 mice per genotype, two-sided Welch's t-Test with 5% FDR multiple-correction. The x-axis represents the intersection ratio between significant genes and the total number of genes for the specific GO category, while the size and colour of dots represent the total count and -log10(p-value) of significant genes for each category, respectively.</p><p>(C) Venn diagram showing the overlap of GA(400) significant targets with the orthologues of the significant hits from <italic>Moens et al., 2019</italic> [<xref ref-type="bibr" rid="R58">58</xref>] and <italic>Bozic et al., 2022</italic> [<xref ref-type="bibr" rid="R9">9</xref>].</p></caption><graphic xlink:href="EMS206142-f004"/></fig></floats-group></article>